High-Throughput Sequencing of Complementarity Determining Region 3 in the Heavy Chain of B-Cell Receptor in Renal Transplant Recipients: A Preliminary Report.

In the group that did not undergo rituximab therapy, but still experienced an initial decline in D50/DI ( Figure 1 c), all 3 patients suffered from TCMR, which occurred after D50/DI showed a decreasing trend.

also in 47,180 other papers